For the year ending 2025-12-31, SRPT made $2,198,237K in revenue. -$713,410K in net income. Net profit margin of -32.45%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 2,198,237 | 1,901,979 | ||
| Cost of sales (excluding amortization of in-licensed rights) | 839,605 | 319,099 | ||
| Research and development | 1,522,066 | 804,522 | ||
| Selling, general and administrative | 491,716 | 557,872 | ||
| Restructuring charge | 42,009 | - | ||
| Amortization of in-licensed rights | 2,622 | 2,405 | ||
| Total cost and expenses | 2,898,018 | 1,683,898 | ||
| Operating (loss) income | -699,781 | 218,081 | ||
| Other (expense) income, net | -19,306 | 42,693 | ||
| Gain (loss) on debt extinguishment | 16,862 | - | ||
| Gain from sale of priority review voucher | 0 | - | ||
| Total other (loss) income, net | -2,444 | 42,693 | ||
| (loss) income before income tax expense | -702,225 | 260,774 | ||
| Income tax expense | 11,185 | 25,535 | ||
| Net (loss) income | -713,410 | 235,239 | ||
| Basic EPS | -7.13 | 2.47 | ||
| Diluted EPS | -7.13 | 2.34 | ||
| Basic Average Shares | 100,120,000 | 95,075,000 | ||
| Diluted Average Shares | 100,120,000 | 107,875,000 | ||
Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics, Inc. (SRPT)